Research ArticleOriginal Article

Clinical features of AIDS patients with Hodgkin’s lymphoma with isolated bone marrow involvement: report of 12 cases at a single institution

Marcelo Corti, Maria Villafañe, Gonzalo Minue, Ana Campitelli, Marina Narbaitz and Leonardo Gilardi
Cancer Biology & Medicine March 2015, 12 (1) 41-45; DOI: https://doi.org/10.7497/j.issn.2095-3941.2014.0024

References

  1. 1.↵
    2. Hessol NA,
    3. Katz MH,
    4. Liu JY,
    5. Buchbinder SP,
    6. Rubino CJ,
    7. Holmberg SD.
    Increased incidence of Hodgkin disease in homosexual men with HIV infection. Ann Intern Med 1992;117:309–311.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    2. Glaser SL,
    3. Clarke CA,
    4. Gulley ML,
    5. Craig FE,
    6. DiGiuseppe JA,
    7. Dorfman RF, et al.
    Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998. Cancer 2003;98:300–309.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    2. Fried G,
    3. Ben Arieh Y,
    4. Haim N,
    5. Dale J,
    6. Stein M.
    Primary Hodgkin’s disease of the bone. Med Pediatr Oncol 1995;24:204–207.
    OpenUrlPubMed
  4. 4.↵
    2. Subramanian R,
    3. Basu D,
    4. Badhe B,
    5. Dutta TK.
    Role of bone marrow trephine biopsy in the diagnosis of marrow involvement in Hodgkin’s disease. Indian J Pathol Microbiol 2007;50:640–643.
    OpenUrlPubMed
  5. 5.↵
    2. Howell SJ,
    3. Grey M,
    4. Chang J,
    5. Morgenstern GR,
    6. Cowan RA,
    7. Deakin DP, et al.
    The value of bone marrow examination in the staging of Hodgkin’s lymphoma: a review of 955 cases seen in a regional cancer centre. Br J Haematol 2002;119:408–411.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    2. Bain BJ.
    Bone marrow trephine biopsy. J Clin Pathol 2001;54:737–742.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    2. Siebert JD,
    3. Stuckey JH,
    4. Kurtin PJ,
    5. Banks PM.
    Extranodal lymphocyte predominance Hodgkin’s disease. Clinical and pathologic features. Am J Clin Pathol 1995;103:485–491.
    OpenUrlCrossRefPubMed
  8. 8.
    2. Swerdlow S,
    3. Campo E,
    4. Harris N,
    5. Jaffe ES,
    6. Pileri S,
    7. Stein H, et al.
    2. Poppema S,
    3. Delsol G,
    4. Pileri S,
    5. Stein H,
    6. Swerdlow S,
    7. Warnke RA, et al.
    Nodular lymphocyte predominant Hodgkin lymphoma. In: Swerdlow S, Campo E, Harris N, Jaffe ES, Pileri S, Stein H, et al. eds. WHO Classification of Tumors of haemopoietic and Lymphoid Tissues. 4th edition. Lyon, France: IARC; 2008, 323#x2013;325.
  9. 9.↵
    2. Munker R,
    3. Hasenclever D,
    4. Brosteanu O,
    5. Hiller E,
    6. Diehl V.
    Bone marrow involvement in Hodgkin’s disease: an analysis of 135 consecutive cases. German Hodgkin’s Lymphoma Study Group. J Clin Oncol 1995;13:403–409.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    2. Noguchi Y,
    3. Hasegawa Y,
    4. Nakazawa M,
    5. Yoda Y,
    6. Abe T,
    7. Mori N.
    Hodgkin’s disease diagnosed from the numerous Reed-Sternberg cells in the bone marrow. Rinsho Ketsueki 1989;30:731–735.
    OpenUrlPubMed
  11. 11.↵
    2. Karcher DS.
    Clinically unsuspected Hodgkin disease presenting initially in the bone marrow of patients infected with the human immunodeficiency virus. Cancer 1993;71:1235–1238.
    OpenUrlCrossRefPubMedWeb of Science
  12. 12.↵
    2. Ponzoni M,
    3. Fumagalli L,
    4. Rossi G,
    5. Freschi M,
    6. Re A,
    7. Viganò MG, et al.
    Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma. Mod Pathol 2002;15:1273–1278.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    2. O’Carroll DI,
    3. McKenna RW,
    4. Brunning RD.
    Bone marrow manifestations of Hodgkin’s disease. Cancer 1976;38:1717–1728.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    2. Corti M,
    3. Soto I,
    4. Villafañe MF,
    5. Minué G,
    6. Campitelli A,
    7. Narbaitz M.
    Bone marrow necrosis as clinical presentation of plasmablastic lymphoma in an AIDS patient: First case reported and literature review. J Hematol Malig 2013;3:57–62.
    OpenUrl
  15. 15.↵
    2. Franco V,
    3. Tripodo C,
    4. Rizzo A,
    5. Stella M,
    6. Florena AM.
    Bone marrow biopsy in Hodgkin’s lymphoma. Eur J Haematol 2004;73:149–155.
    OpenUrlCrossRefPubMed
  16. 16.↵
    2. Hentrich M,
    3. Maretta L,
    4. Chow KU,
    5. Bogner JR,
    6. Schürmann D,
    7. Neuhoff P, et al.
    Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin’s disease: results of a multicenter study. Ann Oncol 2006;17:914–919.
    OpenUrlCrossRefPubMed
  17. 17.↵
    2. Lukes RJ.
    Criteria for involvement of lymph node, bone marrow, spleen, and liver in Hodgkin’s disease. Cancer Res 1971;31:1755–1767.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    2. Steimle-Grauer SA,
    3. Tinguely M,
    4. Seada L,
    5. Fellbaum C,
    6. Hansmann ML.
    Expression patterns of transcription factors in progressively transformed germinal centers and Hodgkin lymphoma. Virchows Arch 2003;442:284–293.
    OpenUrlPubMedWeb of Science
  19. 19.↵
    2. Axdorph U,
    3. Porwit-MacDonald A,
    4. Grimfors G,
    5. Björkholm M.
    Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin’s disease. Leuk Lymphoma 2001;42:1055–1065.
    OpenUrlCrossRefPubMed
  20. 20.↵
    2. Enblad G,
    3. Sundstrom C,
    4. Glimelius B.
    Infiltration of eosinophils in Hodgkin’s disease involved lymph nodes predicts prognosis. Hematol Oncol 1993;11:187–193.
    OpenUrlCrossRefPubMedWeb of Science
  21. 21.↵
    2. Ree HJ,
    3. Strauchen JA,
    4. Khan AA,
    5. Gold JE,
    6. Crowley JP,
    7. Kahn H, et al.
    Human immunodeficiency virus-associated Hodgkin’s disease. Clinicopathologic studies of 24 cases and preponderance of mixed cellularity type characterized by the occurrence of fibrohistiocytoid stromal cells. Cancer 1991;67:1614–1621.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    2. Moog F,
    3. Bangerter M,
    4. Kotzerke J,
    5. Guhlmann A,
    6. Frickhofen N,
    7. Reske SN.
    18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. J Clin Oncol 1998;16:603–609.
    OpenUrlAbstract
  23. 23.↵
    2. Bangerter M,
    3. Moog F,
    4. Buchmann I,
    5. Kotzerke J,
    6. Griesshammer M,
    7. Hafner M, et al.
    Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin’s disease. Ann Oncol 1998;9:1117–1122.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    2. Jerusalem G,
    3. Beguin Y,
    4. Fassotte MF,
    5. Najjar F,
    6. Paulus P,
    7. Rigo P, et al.
    Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin’s disease. Haematologica 2001;86:266–273.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords